D Tio

3PUBLICATIONS
3CO-AUTHORS
Nanoscale characterisationMedical biotechnology diagnostics (incl. biosensors)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 05, 2019
Nine per cent of biopsy-proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery.

J Zoutendijk, D Tio, S Koljenovic

|Dec 24, 2017
Lymphoedema in patients with lentigo maligna treated with imiquimod: a long-term adverse effect.

D Tio, G Kirtschig, R Hoekzema

Pageof 1